National Guideline Clearinghouse | Sunitinib for the treatment of gastrointestinal stromal tumours.

National Institute for Health and Clinical Excellence (NICE).
Guideline Title
Sunitinib for the treatment of gastrointestinal stromal tumours.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Sunitinib for the treatment of gastrointestinal stromal tumours. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Sep. 28 p. (Technology appraisal guidance; no. 179).

Guideline Status
This is the current release of the guideline.

National Guideline Clearinghouse | Sunitinib for the treatment of gastrointestinal stromal tumours.